Literature DB >> 29281760

Long-Term Complications in Patients With Hypoparathyroidism Evaluated by Biochemical Findings: A Case-Control Study.

Line Underbjerg1, Tanja Sikjaer1, Lars Rejnmark1.   

Abstract

Hypoparathyroidism (HypoPT) is associated with an increased risk of various complications, but only few data are available on risk factors. Using a case-control design, we assessed associations between biochemical findings and risk of different complications within a subpopulation of our previously identified Danish patients. We retrieved all biochemical data available on 431 (81% women) patients from the Central Region of Denmark, covering approximately 20% of the Danish population. Average age of patients was 41 years at time of diagnosis. Most patients (88%) had HypoPT due to surgery, mainly due to atoxic goiter and more than 95% were on treatment with calcium supplements and activated vitamin D. On average, time-weighted (tw) plasma levels of ionized calcium (Ca2+tw ) was 1.17 mmol/L (interquartile range [IQR], 1.14 to 1.21 mmol/L) and the calcium-phosphate (CaxPtw ) product was 2.80 mmol2 /L2 (IQR, 2.51 to 3.03 mmol2 /L2 ). High phosphatetw levels were associated with increased mortality and risk of any infections, including infections in the upper airways. A high CaxPtw product was associated with an increased mortality and risk of renal disease. Compared to levels around the lower part of the reference interval, lower Ca2+tw levels were associated with an increased risk of cardiovascular diseases. Mortality and risk of infections, cardiovascular diseases, and renal diseases increased with number of episodes of hypercalcemia and with increased disease duration. Treatment with a relatively high dose of active vitamin D was associated with a decreased mortality and risk of renal diseases and infections. In conclusion, risk of complications in HypoPT is closely associated with disturbances in calcium-phosphate homeostasis.
© 2018 American Society for Bone and Mineral Research. © 2018 American Society for Bone and Mineral Research.

Entities:  

Keywords:  COMPLICATIONS; EPIDEMIOLOGY BIOCHEMISTRY; HYPOPARATHYROIDISM; MORTALITY

Mesh:

Substances:

Year:  2018        PMID: 29281760     DOI: 10.1002/jbmr.3368

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  26 in total

Review 1.  Diagnosis and management of hypocalcemia.

Authors:  Jessica Pepe; Luciano Colangelo; Federica Biamonte; Chiara Sonato; Vittoria Carmela Danese; Veronica Cecchetti; Marco Occhiuto; Valentina Piazzolla; Viviana De Martino; Federica Ferrone; Salvatore Minisola; Cristiana Cipriani
Journal:  Endocrine       Date:  2020-05-04       Impact factor: 3.633

2.  Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety.

Authors:  Yu-Kwang Donovan Tay; Gaia Tabacco; Natalie E Cusano; John Williams; Beatriz Omeragic; Rukshana Majeed; Maximo Gomez Almonte; John P Bilezikian; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

3.  Hypoparathyroidism After Total Thyroidectomy: Importance of the Intraoperative Management of the Parathyroid Glands.

Authors:  Guillermo Ponce de León-Ballesteros; David Velázquez-Fernández; F Javier Hernández-Calderón; Carlos Bonilla-Ramírez; Rafael H Pérez-Soto; Juan Pablo Pantoja; Mauricio Sierra; Miguel F Herrera
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

4.  Permanent postoperative hypoparathyroidism: an analysis of prevalence and predictive factors for adequacy of control in a cohort of 260 patients.

Authors:  Juan J Díez; Emma Anda; Julia Sastre; Begoña Pérez Corral; Cristina Álvarez-Escolá; Laura Manjón; Miguel Paja; Marcel Sambo; Piedad Santiago Fernández; Concepción Blanco Carrera; Juan C Galofré; Elena Navarro; Carles Zafón; Eva Sanz; Amelia Oleaga; Orosia Bandrés; Sergio Donnay; Ana Megía; María Picallo; Cecilia Sánchez Ragnarsson; Gloria Baena-Nieto; José Carlos Fernández-García; Beatriz Lecumberri; Manel Sahún de la Vega; Ana R Romero-Lluch; Pedro Iglesias
Journal:  Gland Surg       Date:  2020-10

5.  Beyond Bone: Infectious Diseases and Immunity in Parathyroid Disorders.

Authors:  Valeria Hasenmajer; Giulia Puliani; Marianna Minnetti; Emilia Sbardella; Claudio M Mastroianni; Gabriella D'Ettorre; Andrea M Isidori; Daniele Gianfrilli
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Hyperphosphatemia is associated with cardiac valve calcification in chronic hypoparathyroidism.

Authors:  S Polonine; R G de Santa Rosa; M L F Farias; M I Garcia; C P Gomes; I Gottlieb; M Madeira
Journal:  J Endocrinol Invest       Date:  2022-03-02       Impact factor: 4.256

7.  Effect of postsurgical chronic hypoparathyroidism on morbidity and mortality: a systematic review and meta-analysis.

Authors:  Deena Hadedeya; Joshua Kay; Abdallah Attia; Mahmoud Omar; Mahmoud Shalaby; Mohanad R Youssef; Mohamed Shama; Eman Toraih; Emad Kandil
Journal:  Gland Surg       Date:  2021-10

8.  Renal complications and quality of life in postsurgical hypoparathyroidism: a case-control study.

Authors:  L Mazoni; A Matrone; M Apicella; F Saponaro; S Borsari; E Pardi; B Cosci; I Biagioni; P Rossi; F Pacciardi; A Scionti; R Elisei; C Marcocci; F Cetani
Journal:  J Endocrinol Invest       Date:  2021-10-12       Impact factor: 4.256

9.  Lower Leg Arterial Calcifications Assessed by High-Resolution Peripheral Quantitative Computed Tomography in Hypoparathyroid and Pseudohypoparathyroid Patients.

Authors:  Catharina Vind Nielsen; Line Underbjerg; Diana Grove-Laugesen; Tanja Sikjaer; Lars Rejnmark
Journal:  Calcif Tissue Int       Date:  2021-02-12       Impact factor: 4.333

10.  Changes in treatment needs for chronic postoperative hypoparathyroidism during initiation of conventional treatment compared to stable phase of treatment.

Authors:  Pernille Storm; Line Underbjerg; Lars Rejnmark
Journal:  Endocrinol Diabetes Metab       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.